Christopher Sumey
Overview
Explore the profile of Christopher Sumey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kelly W, Danila D, Lin C, Lee J, Matsubara N, Ward P, et al.
Cancer Discov
. 2023 Oct;
14(1):76-89.
PMID: 37861461
Significance: Xaluritamig demonstrated encouraging responses (PSA and RECIST) compared with historical established treatments for patients with late-line mCRPC. This study provides proof of concept for T-cell engagers as a potential...
2.
Klubben K, Anderson S, Park E, Sumey C
S D Med
. 2021 Jul;
74(3):108-110.
PMID: 34232588
Solitary fibrous tumors (SFT) are rare mesenchymal neoplasms that can affect any soft tissue in the body. Given their infrequency, no definitive risk factors have been identified. Typically, surgical extrication...
3.
Sorrells S, McKinnon K, McBratney A, Sumey C
NPJ Genom Med
. 2021 Feb;
6(1):17.
PMID: 33619265
BRCA-mutant cancers often develop therapeutic resistance through several mechanisms. Here, we report a case of pathogenic germline BRCA2-driven breast cancer monitored for disease progression and acquired resistance using longitudinal multi-tissue...
4.
Staum B, Sumey C, Bohy K, White K, Thambi-Pillai T, Ridgway T, et al.
S D Med
. 2020 Jun;
73(6):266-269.
PMID: 32580259
IgG4-related disease (IgG4RD) is a chronic immune mediated condition primarily affecting the hepato-pancreatico-biliary system. We report a case of IgG4RD with extensive pancreatic and hepatic involvement masquerading as metastatic pancreatic...
5.
Doebele R, Lu X, Sumey C, Maxson D, Weickhardt A, Oton A, et al.
Cancer
. 2012 Jan;
118(18):4502-11.
PMID: 22282022
Background: The discovery of distinct subsets of nonsmall cell lung cancer (NSCLC) characterized by activation of driver oncogenes has greatly affected personalized therapy. It is hypothesized that the dominant oncogene...
6.
Sumey C, Flaig T
Expert Opin Pharmacother
. 2010 Dec;
12(1):73-84.
PMID: 21118060
Importance Of The Field: Prostate cancer is a common cancer and the role of adjuvant medical therapy continues to be investigated. An understanding of the use of adjuvant medical therapy...